Artivion (AORT) FCF Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.00 |
| Dec 31, 2025 | -1,170.00 |
| Sep 30, 2025 | 592.00 |
| Jun 30, 2025 | 1,899.00 |
| Mar 31, 2025 | -2,095.00 |
| Dec 31, 2024 | 1,152.00 |
| Sep 30, 2024 | -802.00 |
| Jun 30, 2024 | 567.00 |
| Mar 31, 2024 | -930.00 |
| Dec 31, 2023 | -457.00 |
| Sep 30, 2023 | -557.00 |
| Jun 30, 2023 | 599.00 |
| Mar 31, 2023 | 831.00 |
| Dec 31, 2022 | -1,400.00 |
| Sep 30, 2022 | -255.00 |
| Jun 30, 2022 | -393.00 |
| Mar 31, 2022 | -775.00 |
| Dec 31, 2021 | -757.00 |
| Sep 30, 2021 | -2,389.00 |
| Jun 30, 2021 | -1,180.00 |
| Mar 31, 2021 | -776.00 |
| Dec 31, 2020 | 206.00 |
| Sep 30, 2020 | -81.00 |
| Jun 30, 2020 | -1,638.00 |
| Mar 31, 2020 | -57.00 |
| Dec 31, 2019 | -1,253.00 |
| Sep 30, 2019 | 1,199.00 |
| Jun 30, 2019 | -668.00 |
| Mar 31, 2019 | 856.00 |
| Dec 31, 2018 | 97.00 |
| Sep 30, 2018 | -589.00 |
| Jun 30, 2018 | -1,243.00 |
| Mar 31, 2018 | -1,305.00 |
| Dec 31, 2017 | -1,276.00 |
| Sep 30, 2017 | -1,222.00 |
| Jun 30, 2017 | -1,553.00 |
| Mar 31, 2017 | 65.00 |
| Dec 31, 2016 | -298.00 |
| Sep 30, 2016 | -157.00 |
| Jun 30, 2016 | -287.00 |
| Mar 31, 2016 | -1,052.00 |
| Dec 31, 2015 | -1,901.00 |
| Sep 30, 2015 | -57.00 |